Regence BCBS coverage policies

346 active Regence BCBS policies in Backwork, grouped by policy type. Each policy page shows the codes the policy lists and links to the payer’s own copy.

Summary of the payer’s published policy. Not a coverage determination — confirm with Regence BCBS before submitting.

Get free alerts when Regence BCBS updates policies

Free account. Policy pages stay open to everyone.

Policies

51–100 of 346, by type and title

PayerPolicy

REGENCE-GT58

Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies

Effective Aug 1, 2026

REGENCE-LAB46

Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor Cancers

Effective Jul 1, 2026

REGENCE-LAB82

Circulating Tumor-Tissue Modified Viral DNA Testing for Cancer Management

Effective Oct 1, 2025

REGENCE-GT88

ClonoSEQ Testing for the Assessment of Measurable Residual Disease (MRD)

Effective Jul 1, 2026

REGENCE-SUR08

Cochlear Implant

Effective Jun 1, 2025

REGENCE-SUR08a

Cochlear Implant

Effective Oct 1, 2026

REGENCE-RAD06

Computed Tomography to Detect Coronary Artery Calcifications

Effective Apr 1, 2026

REGENCE-RAD59

Cone Beam Computed Tomography of the Breast

Effective Mar 1, 2026

REGENCE-MED151